FIS
53
3
INTU
45
-4
TXT
42
3
O
20
-8
AZO
50
-2
MHK
39
5
AAP
27
-3
PH
57
4
JWN
50
4
RF
48
4
NEM
57
2
CAT
51
7
SLB
42
5
ADM
33
2
MTCH
55
18
C
57
6
IVZ
33
3
UAL
74
-3
TSN
24
4
LMT
44
19
FIS
53
3
INTU
45
-4
TXT
42
3
O
20
-8
AZO
50
-2
MHK
39
5
AAP
27
-3
PH
57
4
JWN
50
4
RF
48
4
NEM
57
2
CAT
51
7
SLB
42
5
ADM
33
2
MTCH
55
18
C
57
6
IVZ
33
3
UAL
74
-3
TSN
24
4
LMT
44
19
Financhill
Back

Summit Therapeutics Vs. Blueprint Medicines Industry Stock Comparison

Sell
46

SMMT
Summit Therapeutics

Last Price:
$16.66
Seasonality Move:
7.78%
Sell
43

BPMC
Blueprint Medicines

Last Price:
$102.47
Seasonality Move:
5.27%
Sell
46
Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics a Buy, Sell or Hold?

  • The current Summit Therapeutics [SMMT] share price is $18.18. The Score for SMMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $103.36. The Score for BPMC is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SMMT Stock Price Chart

What is Summit Therapeutics's stock price today?

  • The Summit Therapeutics share price today is $18.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $103.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

SMMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 48.68 Sell
Chaikin Money Flow: 1356879 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.7 - 18.74) Sell
Bollinger Bands (100): (15.6 - 22.64) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 65.19 Buy
Chaikin Money Flow: 1951173 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.25 - 95.81) Buy
Bollinger Bands (100): (87.04 - 95.76) Buy

SMMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.11 Buy
20-day SMA: 18.21 Sell
50-day SMA: 18.8 Sell
200-day SMA: 12.96 Buy
8-day EMA: 18.17 Buy
20-day EMA: 18.28 Sell
50-day EMA: 18.54 Sell
200-day EMA: 14.22 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.01 Buy
20-day SMA: 91.26 Buy
50-day SMA: 93.56 Buy
200-day SMA: 96.81 Buy
8-day EMA: 92.7 Buy
20-day EMA: 91.91 Buy
50-day EMA: 92.32 Buy
200-day EMA: 91.6 Buy

Summit Therapeutics Earnings Growth & SMMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.16 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.

Summit Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):